News
Momentum for Poolbeg and CytoReason’s AI collaboration
Poolbeg Pharma – a company concentrating on infectious conditions with a high unmet medical need – has announced a notable breakthrough in its world-first influenza artificial intelligence (AI) programme with CytoReason.